11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

1994, Diagnostic and statistical manual of mental disorders, DSM-IV

Archer, 2006, Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study, Ann Neurol, 60, 145, 10.1002/ana.20889

Arnold, 1991, The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cerebral Cortex, 1, 103, 10.1093/cercor/1.1.103

Ashburner, 2000, Voxel-based morphometry–the methods, Neuroimage, 11, 805, 10.1006/nimg.2000.0582

Ashburner, 2005, Unified Segmentation, Neruoimage, 26, 839, 10.1016/j.neuroimage.2005.02.018

Bacskai, 2007, Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report, Arch Neurol, 64, 431, 10.1001/archneur.64.3.431

Baron, 2001, In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease, Neuroimage, 14, 298, 10.1006/nimg.2001.0848

Blomquist, 2005, Influx and net accumulation of PIB compared with CBF in a rhesus monkey, EJNM, 32, S263

Bobinski, 2000, The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease, Neuroscience, 95, 721, 10.1016/S0306-4522(99)00476-5

Braak, 1991, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol, 82, 239, 10.1007/BF00308809

Buckner, 2005, Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory, J Neurosci, 25, 7709, 10.1523/JNEUROSCI.2177-05.2005

Chetelat, 2002, Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment, Brain Imaging, 13, 1939

Christie, 2001, Growth arrest of individual senile plques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy, J Neurosci, 21, 858, 10.1523/JNEUROSCI.21-03-00858.2001

Crystal, 1993, Pathological markers associated with normal aging and dementia in the elderly, Ann Neurol, 34, 566, 10.1002/ana.410340410

Csernansky, 2004, Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subject, Alzheimer Dis Assoc Disord, 18, 190

de Leon, 1989, Early marker for Alzheimer's disease: the atrophic hippocampus, Lancet, 2, 672, 10.1016/S0140-6736(89)90911-2

Edison, 2007, Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study, Neurology, 68, 501, 10.1212/01.wnl.0000244749.20056.d4

Engler, 2006, Two-year follow-up of amyloid deposition in patients with Alzheimer's disease, Brain, 129, 2856, 10.1093/brain/awl178

Fagan, 2006, Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans, Ann Neurol, 59, 512, 10.1002/ana.20730

Folstein, 1975, “Mini Mental State’: a practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Forsberg, 2007, PET imaging of amyloid deposition in patients with mild cognitive impairment, Neurobiol Aging

Fox, 2001, Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images, Lancet, 358, 201, 10.1016/S0140-6736(01)05408-3

Fox, 1996, Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study, Brain, 119, 2001, 10.1093/brain/119.6.2001

Frisoni, 2002, Detection of gray matter loss in mild Alzheimer's disese with voxel-based morphometry, J Neurol Neurosurg Psychiatry, 73, 657, 10.1136/jnnp.73.6.657

Genovese, 2002, Thresholding of statistical maps in functional neuroimaging using the false discovery rate, Neuroimage, 15, 772, 10.1006/nimg.2001.1037

Gosche, 2002, Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study, Neurology, 58, 1476, 10.1212/WNL.58.10.1476

Green, 2000, The Oregon Brain Aging Study, Neurology, 54, 105, 10.1212/WNL.54.1.105

Harrell, 2001, Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis., 1, 10.1007/978-1-4757-3462-1_1

Hulette, 1998, Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals, J Neuropathol Exp Neurol, 57, 1168, 10.1097/00005072-199812000-00009

Hyman, 1993, The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution, J Neuropathol Exp Neurol, 52, 594, 10.1097/00005072-199311000-00006

Jack, 2007, The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods, JMRI

Jack, 1992, MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease, Neurology, 42, 183, 10.1212/WNL.42.1.183

Jack, 1999, Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment, Neurology, 52, 1397, 10.1212/WNL.52.7.1397

Jack, 1998, The rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease, Neurology, 51, 993, 10.1212/WNL.51.4.993

Jack, 1997, Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease, Neurology, 49, 786, 10.1212/WNL.49.3.786

Jack, 2005, Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI, Neurology, 65, 1227, 10.1212/01.wnl.0000180958.22678.91

Jack, 1989, Anterior temporal lobes and hippocampal formations: normative volumetric measurements for MR images in young adults, Radiology, 172, 549, 10.1148/radiology.172.2.2748838

Jack, 2002, Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia, Neurology, 58, 750, 10.1212/WNL.58.5.750

Katzman, 1988, Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques, Ann Neurol, 23, 138, 10.1002/ana.410230206

Kaye, 1997, Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia, Neurology, 48, 1297, 10.1212/WNL.48.5.1297

Kemppainen, 2006, Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease, Neurology, 67, 1575, 10.1212/01.wnl.0000240117.55680.0a

Kemppainen, 2007, PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment, Neurology, 68, 1603, 10.1212/01.wnl.0000260969.94695.56

Killiany, 2002, MRI measures of entorhinal cortex vs hippocampus in preclinical AD, Neurology, 58, 1188, 10.1212/WNL.58.8.1188

Kinniany, 1993, Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease, Arch Neurol, 50, 949, 10.1001/archneur.1993.00540090052010

Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009

Knopman, 2003, Neuropathology of cognitively normal elderly, J Neuropathol Exp Neurol, 62, 1087, 10.1093/jnen/62.11.1087

Kokmen, 1991, The short test of mental status: correlations with standardized psychometric testing, Arch Neurol, 48, 725, 10.1001/archneur.1991.00530190071018

Laakso, 1998, MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects, Neurobiol Aging, 19, 23, 10.1016/S0197-4580(98)00006-2

Lopresti, 2005, Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis, J Nucl Med, 46, 1959

Mathis, 2003, Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents, J Med Chem, 46, 2740, 10.1021/jm030026b

McCullagh, 1980, Regression models for ordinal data, J R Stat S Ser B (Methodol), 42, 109

McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Meltzer, 1999, Comparative evaluation of MR-based partial-volume correction schemes for PET, J Nucl Med, 40, 2053

Mintun, 2006, [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease, Neurology, 67, 446, 10.1212/01.wnl.0000228230.26044.a4

Morris, 2001, Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's Disease, J Mol Neurosci, 17, 101, 10.1385/JMN:17:2:101

Morris, 1993, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a

Nichols, 2005, Valid conjunction inference with the minimum statistic, Neuroimage, 25, 653, 10.1016/j.neuroimage.2004.12.005

O’Brien, 1995, Procedures for setting normal values, Neurology, 45, 17, 10.1212/WNL.45.1.17

Petersen, 1995, Normal aging, mild cognitive impairment, and early Alzheimer's disease, The Neurologist, 1, 326

Petersen, 2001, Current concepts in mild cognitive impairment, Arch Neurol, 58, 1985, 10.1001/archneur.58.12.1985

Petersen, 1990, Mayo Clinic Alzheimer's Disease Patient Registry, Aging, 2, 408

Petersen, 1995, Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals, JAMA, 273, 1274, 10.1001/jama.1995.03520400044042

Pike, 2007, Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease, Brain, 130, 2837, 10.1093/brain/awm238

Price, 2005, Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B, J Cereb Blood Flow Metab, 25, 1528, 10.1038/sj.jcbfm.9600146

Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease, Ann Neurol, 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X

Rabinovici, 2007, 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration, Neurology, 68, 1205, 10.1212/01.wnl.0000259035.98480.ed

1964, Rey A.2 L'examen clinique en psychologie, 1

Riley, 2002, Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findigns from the Nun Study, Ann Neurol, 51, 567, 10.1002/ana.10161

Rombouts, 2000, Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease, Neurosci Lett, 285, 231, 10.1016/S0304-3940(00)01067-3

Rowe, 2007, Imaging {beta}-amyloid burden in aging and dementia, Neurology, 68, 1718, 10.1212/01.wnl.0000261919.22630.ea

Schmitt, 2000, “Preclinical” AD revisted: neuropathology of cognitively normal older adults, Neurology, 55, 370, 10.1212/WNL.55.3.370

Senjem, 2005, Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease, Neuroimage, 26, 600, 10.1016/j.neuroimage.2005.02.005

Silbert, 2003, Changes in premorbid brain volume predict Alzheimer's disease pathology, Neurology, 61, 487, 10.1212/01.WNL.0000079053.77227.14

Small, 2006, PET of brain amyloid and Tau in mild cognitive impairment, N Engl J Med, 355, 2652, 10.1056/NEJMoa054625

Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer's disease, The Nun Study, JAMA, 277, 813, 10.1001/jama.1997.03540340047031

Sun, 2007, Automated templeate-based PET region of interest analyses in the aging brain, Neuroimage, 34, 608, 10.1016/j.neuroimage.2006.09.022

Tang-Wai, 2003, Comparison of Short Test of Mental Status and Mini Mental State Examination in mild cognitive impairment, Arch Neurol, 60, 1777, 10.1001/archneur.60.12.1777

Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410

Thal, 2002, Phases of Ab-deposition in the human brain and its relevance for the development of AS, Neurology, 58, 1791, 10.1212/WNL.58.12.1791

Troncoso, 1996, Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging, Neurobiol Aging, 17, 365, 10.1016/0197-4580(96)00028-0

Tzourio-Mazoyer, 2002, Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain, Neuroimage, 15, 273, 10.1006/nimg.2001.0978

Verhoeff, 2004, In-vivo imaging of Alzheimer disese beta=amyloid with (11C)SB-13 PET, Am J Geriatr Psychiatry, 12, 584

Visser, 1999, Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment, J Neurol, 246, 477, 10.1007/s004150050387

Wechsler, 1987, Wechsler Memory Scale-Revised

White, 2005, Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study, J Geriatr Psychiatr Neurol, 18, 224, 10.1177/0891988705281872

Whitwell, 2007, MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment, Neurology

Whitwell, 2007, Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease, Brain, 130, 708, 10.1093/brain/awl388

Zarow, 2005, Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia, Ann Neurol, 57, 896, 10.1002/ana.20503